Singapore markets close in 6 hours 21 minutes
Straits Times Index
3,185.78 +31.09 (+0.99%) Nikkei
38,019.29 +57.49 (+0.15%) Hang Seng
16,392.73 +140.89 (+0.87%) FTSE 100
7,847.99 +27.63 (+0.35%) Bitcoin USD
61,556.55 -2,395.33 (-3.75%) CMC Crypto 200
885.54 0.00 (0.00%)
Phathom Pharmaceuticals, Inc. (PHAT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 587.00M |
| Enterprise value | 344.63M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 754.30 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 505.33 |
| Enterprise value/EBITDA | -2.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.63 |
| 52-week change 3 | -5.22% |
| S&P500 52-week change 3 | 21.61% |
| 52-week high 3 | 17.02 |
| 52-week low 3 | 6.07 |
| 50-day moving average 3 | 9.44 |
| 200-day moving average 3 | 10.31 |
Share statistics
| Avg vol (3-month) 3 | 911.58k |
| Avg vol (10-day) 3 | 951.05k |
| Shares outstanding 5 | 58.52M |
| Implied shares outstanding 6 | 59.24M |
| Float 8 | 43.24M |
| % held by insiders 1 | 8.80% |
| % held by institutions 1 | 87.79% |
| Shares short (28 Mar 2024) 4 | 10.65M |
| Short ratio (28 Mar 2024) 4 | 12.09 |
| Short % of float (28 Mar 2024) 4 | 26.13% |
| Short % of shares outstanding (28 Mar 2024) 4 | 18.21% |
| Shares short (prior month 29 Feb 2024) 4 | 8.67M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -10,245.60% |
Management effectiveness
| Return on assets (ttm) | -36.14% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 682k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -166.74M |
| Net income avi to common (ttm) | -201.59M |
| Diluted EPS (ttm) | -3.93 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 381.39M |
| Total cash per share (mrq) | 6.52 |
| Total debt (mrq) | 445.96M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 10.25 |
| Book value per share (mrq) | -1.25 |
Cash flow statement
| Operating cash flow (ttm) | -137.58M |
| Levered free cash flow (ttm) | -90.45M |
© 2024 Yahoo. All rights reserved.